- call +1-201-465-4211
- email sales@mrinsights.biz
Cath labs or cardiac catheterization laboratories in hospitals conduct both diagnostic and therapeutic procedures. These laboratories are used to conduct normal procedures such as the monitoring of blood flow and heart pressure. Advances in catheterization technology such as robot-assisted catheterization for cardiac catheterization have advanced the digital imaging system. One driver in market is growing focus on clinical trials. Vendors are using advanced technologies to develop innovative ablation catheters. They invest in R&D to develop cost-effective and efficient devices and lower manufacturing costs. Many of these devices are awaiting approval across different countries.
Scope of the Report:
This report focuses on the Cardiac Ablation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
One of the primary drivers for this market is the rise in the adoption of minimally invasive procedures with improved medical imaging. Medical facilities across the world are shifting toward minimally invasive procedures, which involve the use of radiotherapy and imaging technologies and expand the treatment options for cardiac diseases such as atrial fibrillation. Through imaging, the anatomy of the heart can be studied, which helps the physician diagnose and conduct cardiac ablation procedure. For instance, fluoroscopy imaging is used for most of the complex atrial fibrillation procedures; fluoroscopy imaging modality is used to guide the catheter and improve the surgical outcome. These advantages of medical imaging are expected to propel growth in the global cardiac ablation market during the forecast period.
The emerging markets including China, India, Brazil, and Mexico have become attractive destinations for companies engaged in the development, manufacturing, and distribution of cardiac ablation products. A number of factors such as success of microwave ablation procedure in clinical trials to treat atrial fibrillation, growing adoption of ablation in CVS disease treatment, and growing market penetration of ablation product manufacturers across developing countries are offering high growth opportunities for the players’ active in the Cardiac ablation market.
The worldwide market for Cardiac Ablation is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Boston Scientific
Medtronic
St. Jude Medical
AblaCor
Advanced Cardiac Therapeutics
AngioDynamics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Irreversible Electroporation
HIFU
MRgFUS
Market Segment by Applications, can be divided into
Cardiac Arrhythmia
Atrial Fibrillation
Tachycardia
Open Surgery
There are 15 Chapters to deeply display the global Cardiac Ablation market.
Chapter 1, to describe Cardiac Ablation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Cardiac Ablation, with sales, revenue, and price of Cardiac Ablation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Cardiac Ablation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Cardiac Ablation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Cardiac Ablation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Cardiac Ablation Introduction
1.2 Market Analysis by Type
1.2.1 Irreversible Electroporation
1.2.2 HIFU
1.2.3 MRgFUS
1.3 Market Analysis by Applications
1.3.1 Cardiac Arrhythmia
1.3.2 Atrial Fibrillation
1.3.3 Tachycardia
1.3.4 Open Surgery
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boston Scientific
2.1.1 Business Overview
2.1.2 Cardiac Ablation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boston Scientific Cardiac Ablation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Medtronic
2.2.1 Business Overview
2.2.2 Cardiac Ablation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medtronic Cardiac Ablation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 St. Jude Medical
2.3.1 Business Overview
2.3.2 Cardiac Ablation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 St. Jude Medical Cardiac Ablation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 AblaCor
2.4.1 Business Overview
2.4.2 Cardiac Ablation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 AblaCor Cardiac Ablation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Advanced Cardiac Therapeutics
2.5.1 Business Overview
2.5.2 Cardiac Ablation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Advanced Cardiac Therapeutics Cardiac Ablation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 AngioDynamics
2.6.1 Business Overview
2.6.2 Cardiac Ablation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AngioDynamics Cardiac Ablation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cardiac Ablation Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Cardiac Ablation Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Cardiac Ablation Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Cardiac Ablation Manufacturer Market Share in 2017
3.3.2 Top 6 Cardiac Ablation Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Cardiac Ablation Market Analysis by Regions
4.1 Global Cardiac Ablation Sales, Revenue and Market Share by Regions
4.1.1 Global Cardiac Ablation Sales and Market Share by Regions (2013-2018)
4.1.2 Global Cardiac Ablation Revenue and Market Share by Regions (2013-2018)
4.2 North America Cardiac Ablation Sales and Growth Rate (2013-2018)
4.3 Europe Cardiac Ablation Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Cardiac Ablation Sales and Growth Rate (2013-2018)
4.5 South America Cardiac Ablation Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Cardiac Ablation Sales and Growth Rate (2013-2018)
5 North America Cardiac Ablation by Countries
5.1 North America Cardiac Ablation Sales, Revenue and Market Share by Countries
5.1.1 North America Cardiac Ablation Sales and Market Share by Countries (2013-2018)
5.1.2 North America Cardiac Ablation Revenue and Market Share by Countries (2013-2018)
5.2 United States Cardiac Ablation Sales and Growth Rate (2013-2018)
5.3 Canada Cardiac Ablation Sales and Growth Rate (2013-2018)
5.4 Mexico Cardiac Ablation Sales and Growth Rate (2013-2018)
6 Europe Cardiac Ablation by Countries
6.1 Europe Cardiac Ablation Sales, Revenue and Market Share by Countries
6.1.1 Europe Cardiac Ablation Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Cardiac Ablation Revenue and Market Share by Countries (2013-2018)
6.2 Germany Cardiac Ablation Sales and Growth Rate (2013-2018)
6.3 UK Cardiac Ablation Sales and Growth Rate (2013-2018)
6.4 France Cardiac Ablation Sales and Growth Rate (2013-2018)
6.5 Russia Cardiac Ablation Sales and Growth Rate (2013-2018)
6.6 Italy Cardiac Ablation Sales and Growth Rate (2013-2018)
7 Asia-Pacific Cardiac Ablation by Countries
7.1 Asia-Pacific Cardiac Ablation Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cardiac Ablation Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Cardiac Ablation Revenue and Market Share by Countries (2013-2018)
7.2 China Cardiac Ablation Sales and Growth Rate (2013-2018)
7.3 Japan Cardiac Ablation Sales and Growth Rate (2013-2018)
7.4 Korea Cardiac Ablation Sales and Growth Rate (2013-2018)
7.5 India Cardiac Ablation Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Cardiac Ablation Sales and Growth Rate (2013-2018)
8 South America Cardiac Ablation by Countries
8.1 South America Cardiac Ablation Sales, Revenue and Market Share by Countries
8.1.1 South America Cardiac Ablation Sales and Market Share by Countries (2013-2018)
8.1.2 South America Cardiac Ablation Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Cardiac Ablation Sales and Growth Rate (2013-2018)
8.3 Argentina Cardiac Ablation Sales and Growth Rate (2013-2018)
8.4 Colombia Cardiac Ablation Sales and Growth Rate (2013-2018)
9 Middle East and Africa Cardiac Ablation by Countries
9.1 Middle East and Africa Cardiac Ablation Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cardiac Ablation Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Cardiac Ablation Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Cardiac Ablation Sales and Growth Rate (2013-2018)
9.3 UAE Cardiac Ablation Sales and Growth Rate (2013-2018)
9.4 Egypt Cardiac Ablation Sales and Growth Rate (2013-2018)
9.5 Nigeria Cardiac Ablation Sales and Growth Rate (2013-2018)
9.6 South Africa Cardiac Ablation Sales and Growth Rate (2013-2018)
10 Global Cardiac Ablation Market Segment by Type
10.1 Global Cardiac Ablation Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Cardiac Ablation Sales and Market Share by Type (2013-2018)
10.1.2 Global Cardiac Ablation Revenue and Market Share by Type (2013-2018)
10.2 Irreversible Electroporation Sales Growth and Price
10.2.1 Global Irreversible Electroporation Sales Growth (2013-2018)
10.2.2 Global Irreversible Electroporation Price (2013-2018)
10.3 HIFU Sales Growth and Price
10.3.1 Global HIFU Sales Growth (2013-2018)
10.3.2 Global HIFU Price (2013-2018)
10.4 MRgFUS Sales Growth and Price
10.4.1 Global MRgFUS Sales Growth (2013-2018)
10.4.2 Global MRgFUS Price (2013-2018)
11 Global Cardiac Ablation Market Segment by Application
11.1 Global Cardiac Ablation Sales Market Share by Application (2013-2018)
11.2 Cardiac Arrhythmia Sales Growth (2013-2018)
11.3 Atrial Fibrillation Sales Growth (2013-2018)
11.4 Tachycardia Sales Growth (2013-2018)
11.5 Open Surgery Sales Growth (2013-2018)
12 Cardiac Ablation Market Forecast (2018-2023)
12.1 Global Cardiac Ablation Sales, Revenue and Growth Rate (2018-2023)
12.2 Cardiac Ablation Market Forecast by Regions (2018-2023)
12.2.1 North America Cardiac Ablation Market Forecast (2018-2023)
12.2.2 Europe Cardiac Ablation Market Forecast (2018-2023)
12.2.3 Asia-Pacific Cardiac Ablation Market Forecast (2018-2023)
12.2.4 South America Cardiac Ablation Market Forecast (2018-2023)
12.2.5 Middle East and Africa Cardiac Ablation Market Forecast (2018-2023)
12.3 Cardiac Ablation Market Forecast by Type (2018-2023)
12.3.1 Global Cardiac Ablation Sales Forecast by Type (2018-2023)
12.3.2 Global Cardiac Ablation Market Share Forecast by Type (2018-2023)
12.4 Cardiac Ablation Market Forecast by Application (2018-2023)
12.4.1 Global Cardiac Ablation Sales Forecast by Application (2018-2023)
12.4.2 Global Cardiac Ablation Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Cardiac Ablation Picture
Table Product Specifications of Cardiac Ablation
Figure Global Sales Market Share of Cardiac Ablation by Types in 2017
Table Ca
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
